Neurogene (NasdaqGM:NGNE) 2026 Conference Transcript

Neurogene (NasdaqGM:NGNE) 2026 Conference March 09, 2026 01:40 PM ET Company ParticipantsRachel McMinn - Founder and CEOConference Call ParticipantsMarc Frahm - Managing Director and Senior Equity AnalystMarc FrahmWelcome back to our afternoon session of the first day of the Leerink Partners Global Healthcare Conference here in Miami. I'm still Marc Frahm, Senior Analyst at TD Cowen, and I have with me Rachel McMinn, CEO of Neurogene. Rachel, how are you doing?Rachel McMinnI'm good. I'm good. Thank you for ...